Experimental and Clinical Studies on the Antifibrinolytic and Presumed Antithrombotic Effect of a Kallikrein Inhibitor (Trasylol)

References

• Amris C. J. Inhibition of fibrinolytic and thrombo-plastic activity by Trasylol. Abstr. Xth Congr Internal Soc Haemat. Stockholm 1964; G 72
   Google Scholar
• Amris C. J. Inhibition of fibrinolytic and thromboplastic activity by Trasylol. Scand J Haemat 1966; 3: 19
   PubMedGoogle Scholar
• Andersson L. Treatment of so-called essential haematuria with fibrinolytic inhibitor (Epsilon-aminocaproic acid). Acta Chir Scand 1962; 124: 355
   Google Scholar
• Andersson L. Combined prophylaxis of haemorrhage and thrombosis after prostatectomy. Acta Chir Scand 1965; 130: 393
   PubMedGoogle Scholar
• Andersson L., Nilsson I. M., Niléhn J.-E., Hedner U., Granstrand B., Melander B. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haemat 1965; 2: 230
   PubMedGoogle Scholar
• Beck E., Schmutzler R., Duckert F. Inhibition of fibrinolysis and fibrinogenolysis in man: comparison of -aminocaproic acid and kallikrein inhibitor. Thromb Diathes Haemorrh 1963; 10: 106
   PubMedGoogle Scholar
• Benzer H., Blümel G., Piza F. Einflüsse von Trypsininhibitoren auf die Blutgerinnung. Wien Med Wschr 1960; 110: 609
   Google Scholar
• Berghoff A., Glatzel H. über die Hemmung des fibrinolytischen Potentials durch Trasylol. Med Klin 1963; 58: 476
   PubMedGoogle Scholar
• Blombäck B., Blombäck M. Purification of human and bovine fibrinogen. Arkiv för Kemi 1956; 10: 415
   Google Scholar
• Borgström S. Investigation on the effect of dicumarol and early ambulation in the prevention of postoperative thrombo-embolism in a surgical material strongly disposed to thrombosis. Acta Chir Scand Suppl. 1950; 150: 32
   Google Scholar
• Cronberg S., Nilsson I. M., Silwer J. Studies on the platelet adhesiveness in von Willebrand's disease. Acta Med Scand. 1966, In press.
   Google Scholar
• Gormsen J., Haxholdt B. F. The heparin tolerance test and thrombo-embolic incidence in surgery. Acta Chir Scand 1960; 120: 121
   PubMedGoogle Scholar
• Hedner U., Nilsson I. M. Determination of plas-minogen in human plasma by a casein method. Thromb Diathes Haemorrh 1965; 14: 545
   PubMedGoogle Scholar
• Kline D. L. Purification and crystallization of plasminogen (profibrinolysin). J Biol Chem 1953; 204: 949
   PubMed Web of Science ®Google Scholar
• Laurell A. B., Nilsson I. M. Hypergammaglo-bulinemia, circulating anticoagulant and biologic false positive Wasserman reaction. J Lab Clin Med 1957; 49: 694
   PubMed Web of Science ®Google Scholar
• Marx R. Wirkungsweise der Fibrinolytika und Antifibrinolytika. Thromb Diathes Haemorrh 1963; 7: 27, Suppl. 3
   Google Scholar
• Marx R., Clemente P., Werle E., Appel W. Zum Problem eines Antidotes in der internen Thrombo-therapie mit Fibrinolytika. Blut 1959; 5: 367
   PubMedGoogle Scholar
• Marx R. über die Wirkung von Proteinaseinhibitor-Präparaten (Leber-und Parotisinhibitor) auf die extravasale Fibrinolyse und Blutgerinnungskonstanten im Menschenblut. Blut 1963; 9: 164
   PubMedGoogle Scholar
• Müllertz S. Formation and properties of the activator of plasminogen and of human and bovin plas-min. Biochem J 1955; 61: 424
   PubMed Web of Science ®Google Scholar
• Niléhn J., Nilsson I. M. Demonstration of fibrinolytic split products in human serum by an immu-nological method in spontaneous and induced fibrinolytic states. Scand J Haemat 1964; 1: 313
   PubMedGoogle Scholar
• Nilsson I. M., Andersson L., Bjärkman S. E. Epsilon-aminocaproic acid (c-ACA) as a therapeutic agent. Based on 5 year's clinical experience. Acta Med Scand 1966; 180, Suppl. 448
   Google Scholar
• Nilsson I. M., Blombäck M., Francken I. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 159: 35
   PubMedGoogle Scholar
• Nilsson I. M., Blombäck M., Ramgren O. Hemophilia in Sweden. I. Coagulation studies. Acta Med Scand 1961; 170: 665
   PubMedGoogle Scholar
• Nilsson I. M., Krook H., Sternby N.-H., Säderberg E., Sädersträm N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand 1961; 169: 323
   PubMed Web of Science ®Google Scholar
• Nilsson I. M., Olow B. Fibrinolysis induced by streptokinase in man. Acta Chir Scand 1962; 123: 247
   Google Scholar
• Nilsson I. Determination of fibrinogen and fibrinogenolytic activity. Thromb Diathes Haemorrh 1962; 8: 297
   PubMedGoogle Scholar
• Nordström S., Blombäck B., Olsson P., Blombäck M., Zetterqvist E. Experimental investigations on the antithromboplastic and antifibrinolytic activity of Trasylol. Ann N.Y. Acad Sci. 1966, In press.
   Web of Science ®Google Scholar
• Okamoto S. Ref. to British Patent Specification. 1957; 770: 693
   Google Scholar
• Olsson P., Nordström S. The significance of postoperative variations in antithrombins. Thoraxchirurgie 1964; 12: 176
   Google Scholar
• Oncley J. L., Melin M., Richert D. A., Cameron J. W., Gross P. M., Jr. The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and β1-lipoprotein into subtractions of human plasma. J Amer Chem Soc 1949; 71: 541
   PubMed Web of Science ®Google Scholar
• Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest 1962; 14: 138
   PubMed Web of Science ®Google Scholar
• Schmutzler R., Beck E. Die Wirkung von -Amino-capronsäure und Trasylol auf die Fibrinolyse. Schweiz Med Wschr 1962; 43: 1368
   Google Scholar
• Schmutzler R., Fürstenberg H. Fibrinolyse und Blutverlust nach Prostata-Operationen und deren Beeinflussbarkeit durch Antifibrinolytika. Deutsch Med Wschr 1966; 91: 297
   PubMed Web of Science ®Google Scholar
• Soulier J. P., Prou-Wartelle O., Dormont J. Etude de divers inhibiteurs d'enzymes protéolytiques sur la coagulation et la fibrinolyse. Rev d'Hémat 1960; 15: 431
   Google Scholar
• Steichele D. F., Herschlein H. J. Zur antifibrino-lytischen Wirkung des Trypsin-Kallikrein-Inaktivators. Med Welt 1961; 2170
   PubMedGoogle Scholar
• Wallén P. Studies on the purification of human plasminogen. Arkiv för Kemi 1962; 19: 451
   Google Scholar
• Werle E., Trautschold I. Bestimmung des Kallikrein Inaktivators “Trasylol” im Blut und in Organen und seine Verteilung nach Injektionen. Munch Med Wschr 1961; 103: 773
   PubMedGoogle Scholar